The Market Reports

Index

1 Biosimilars/Follow-on-Biologics Market Overview
1.1 Product Overview and Scope of Biosimilars/Follow-on-Biologics
1.2 Biosimilars/Follow-on-Biologics Segment by Type
1.2.1 Global Biosimilars/Follow-on-Biologics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Human Growth Hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal Antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Peptide
1.2.9 Others
1.3 Biosimilars/Follow-on-Biologics Segment by Application
1.3.1 Global Biosimilars/Follow-on-Biologics Sales Comparison by Application: (2021-2027)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Global Biosimilars/Follow-on-Biologics Market Size Estimates and Forecasts
1.4.1 Global Biosimilars/Follow-on-Biologics Revenue 2016-2027
1.4.2 Global Biosimilars/Follow-on-Biologics Sales 2016-2027
1.4.3 Biosimilars/Follow-on-Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Biosimilars/Follow-on-Biologics Market Competition by Manufacturers
2.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilars/Follow-on-Biologics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilars/Follow-on-Biologics Manufacturing Sites, Area Served, Product Type
2.5 Biosimilars/Follow-on-Biologics Market Competitive Situation and Trends
2.5.1 Biosimilars/Follow-on-Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilars/Follow-on-Biologics Players Market Share by Revenue
2.5.3 Global Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biosimilars/Follow-on-Biologics Retrospective Market Scenario by Region
3.1 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Biosimilars/Follow-on-Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Biosimilars/Follow-on-Biologics Market Facts & Figures by Country
3.3.1 North America Biosimilars/Follow-on-Biologics Sales by Country
3.3.2 North America Biosimilars/Follow-on-Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilars/Follow-on-Biologics Market Facts & Figures by Country
3.4.1 Europe Biosimilars/Follow-on-Biologics Sales by Country
3.4.2 Europe Biosimilars/Follow-on-Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilars/Follow-on-Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region
3.5.2 Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biosimilars/Follow-on-Biologics Market Facts & Figures by Country
3.6.1 Latin America Biosimilars/Follow-on-Biologics Sales by Country
3.6.2 Latin America Biosimilars/Follow-on-Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilars/Follow-on-Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country
3.7.2 Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biosimilars/Follow-on-Biologics Historic Market Analysis by Type
4.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2016-2021)
4.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Type (2016-2021)
4.3 Global Biosimilars/Follow-on-Biologics Price by Type (2016-2021)

5 Global Biosimilars/Follow-on-Biologics Historic Market Analysis by Application
5.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2016-2021)
5.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Application (2016-2021)
5.3 Global Biosimilars/Follow-on-Biologics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Biosimilars/Follow-on-Biologics Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Synthon Pharmaceuticals
6.2.1 Synthon Pharmaceuticals Corporation Information
6.2.2 Synthon Pharmaceuticals Description and Business Overview
6.2.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Portfolio
6.2.5 Synthon Pharmaceuticals Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Corporation Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 LG Life Sciences
6.4.1 LG Life Sciences Corporation Information
6.4.2 LG Life Sciences Description and Business Overview
6.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LG Life Sciences Biosimilars/Follow-on-Biologics Product Portfolio
6.4.5 LG Life Sciences Recent Developments/Updates
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Description and Business Overview
6.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Celltrion Biosimilars/Follow-on-Biologics Product Portfolio
6.5.5 Celltrion Recent Developments/Updates
6.6 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Biocon Biosimilars/Follow-on-Biologics Product Portfolio
6.6.5 Biocon Recent Developments/Updates
6.7 Hospira
6.6.1 Hospira Corporation Information
6.6.2 Hospira Description and Business Overview
6.6.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hospira Biosimilars/Follow-on-Biologics Product Portfolio
6.7.5 Hospira Recent Developments/Updates
6.8 Merck Group
6.8.1 Merck Group Corporation Information
6.8.2 Merck Group Description and Business Overview
6.8.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck Group Biosimilars/Follow-on-Biologics Product Portfolio
6.8.5 Merck Group Recent Developments/Updates
6.9 Biogen idec, Inc.
6.9.1 Biogen idec, Inc. Corporation Information
6.9.2 Biogen idec, Inc. Description and Business Overview
6.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Portfolio
6.9.5 Biogen idec, Inc. Recent Developments/Updates
6.10 Genentech (Roche Group)
6.10.1 Genentech (Roche Group) Corporation Information
6.10.2 Genentech (Roche Group) Description and Business Overview
6.10.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Portfolio
6.10.5 Genentech (Roche Group) Recent Developments/Updates

7 Biosimilars/Follow-on-Biologics Manufacturing Cost Analysis
7.1 Biosimilars/Follow-on-Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
7.4 Biosimilars/Follow-on-Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilars/Follow-on-Biologics Distributors List
8.3 Biosimilars/Follow-on-Biologics Customers

9 Biosimilars/Follow-on-Biologics Market Dynamics
9.1 Biosimilars/Follow-on-Biologics Industry Trends
9.2 Biosimilars/Follow-on-Biologics Growth Drivers
9.3 Biosimilars/Follow-on-Biologics Market Challenges
9.4 Biosimilars/Follow-on-Biologics Market Restraints

10 Global Market Forecast
10.1 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilars/Follow-on-Biologics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics by Type (2022-2027)
10.2 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilars/Follow-on-Biologics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics by Application (2022-2027)
10.3 Biosimilars/Follow-on-Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilars/Follow-on-Biologics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Biosimilars/Follow-on-Biologics Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biosimilars/Follow-on-Biologics Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Biosimilars/Follow-on-Biologics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biosimilars/Follow-on-Biologics Covered in This Study
Table 5. Global Biosimilars/Follow-on-Biologics Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Biosimilars/Follow-on-Biologics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Biosimilars/Follow-on-Biologics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biosimilars/Follow-on-Biologics Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biosimilars/Follow-on-Biologics Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilars/Follow-on-Biologics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilars/Follow-on-Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/Follow-on-Biologics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilars/Follow-on-Biologics Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2016-2021)
Table 17. Global Biosimilars/Follow-on-Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biosimilars/Follow-on-Biologics Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2016-2021)
Table 20. North America Biosimilars/Follow-on-Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2016-2021)
Table 22. Europe Biosimilars/Follow-on-Biologics Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Biosimilars/Follow-on-Biologics Sales Market Share by Country (2016-2021)
Table 24. Europe Biosimilars/Follow-on-Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biosimilars/Follow-on-Biologics Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Biosimilars/Follow-on-Biologics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biosimilars/Follow-on-Biologics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biosimilars/Follow-on-Biologics Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Biosimilars/Follow-on-Biologics Sales Market Share by Country (2016-2021)
Table 32. Latin America Biosimilars/Follow-on-Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biosimilars/Follow-on-Biologics Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Biosimilars/Follow-on-Biologics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biosimilars/Follow-on-Biologics Revenue Market Share by Country (2016-2021)
Table 38. Global Biosimilars/Follow-on-Biologics Sales (K Pcs) by Type (2016-2021)
Table 39. Global Biosimilars/Follow-on-Biologics Sales Market Share by Type (2016-2021)
Table 40. Global Biosimilars/Follow-on-Biologics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biosimilars/Follow-on-Biologics Revenue Share by Type (2016-2021)
Table 42. Global Biosimilars/Follow-on-Biologics Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Biosimilars/Follow-on-Biologics Sales (K Pcs) by Application (2016-2021)
Table 44. Global Biosimilars/Follow-on-Biologics Sales Market Share by Application (2016-2021)
Table 45. Global Biosimilars/Follow-on-Biologics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biosimilars/Follow-on-Biologics Revenue Share by Application (2016-2021)
Table 47. Global Biosimilars/Follow-on-Biologics Price (USD/Pcs) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Novartis Biosimilars/Follow-on-Biologics Product
Table 52. Novartis Recent Developments/Updates
Table 53. Synthon Pharmaceuticals Corporation Information
Table 54. Synthon Pharmaceuticals Description and Business Overview
Table 55. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product
Table 57. Synthon Pharmaceuticals Recent Developments/Updates
Table 58. Teva Pharmaceutical Industries Corporation Information
Table 59. Teva Pharmaceutical Industries Description and Business Overview
Table 60. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product
Table 62. Teva Pharmaceutical Industries Recent Developments/Updates
Table 63. LG Life Sciences Corporation Information
Table 64. LG Life Sciences Description and Business Overview
Table 65. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. LG Life Sciences Biosimilars/Follow-on-Biologics Product
Table 67. LG Life Sciences Recent Developments/Updates
Table 68. Celltrion Corporation Information
Table 69. Celltrion Description and Business Overview
Table 70. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Celltrion Biosimilars/Follow-on-Biologics Product
Table 72. Celltrion Recent Developments/Updates
Table 73. Biocon Corporation Information
Table 74. Biocon Description and Business Overview
Table 75. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Biocon Biosimilars/Follow-on-Biologics Product
Table 77. Biocon Recent Developments/Updates
Table 78. Hospira Corporation Information
Table 79. Hospira Description and Business Overview
Table 80. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Hospira Biosimilars/Follow-on-Biologics Product
Table 82. Hospira Recent Developments/Updates
Table 83. Merck Group Corporation Information
Table 84. Merck Group Description and Business Overview
Table 85. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Merck Group Biosimilars/Follow-on-Biologics Product
Table 87. Merck Group Recent Developments/Updates
Table 88. Biogen idec, Inc. Corporation Information
Table 89. Biogen idec, Inc. Description and Business Overview
Table 90. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product
Table 92. Biogen idec, Inc. Recent Developments/Updates
Table 93. Genentech (Roche Group) Corporation Information
Table 94. Genentech (Roche Group) Description and Business Overview
Table 95. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product
Table 97. Genentech (Roche Group) Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Biosimilars/Follow-on-Biologics Distributors List
Table 101. Biosimilars/Follow-on-Biologics Customers List
Table 102. Biosimilars/Follow-on-Biologics Market Trends
Table 103. Biosimilars/Follow-on-Biologics Growth Drivers
Table 104. Biosimilars/Follow-on-Biologics Market Challenges
Table 105. Biosimilars/Follow-on-Biologics Market Restraints
Table 106. Global Biosimilars/Follow-on-Biologics Sales Forecast by Type (2022-2027) & (K Pcs)
Table 107. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Biosimilars/Follow-on-Biologics Sales Forecast by Application (2022-2027) & (K Pcs)
Table 111. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Biosimilars/Follow-on-Biologics Sales Forecast by Region (2022-2027) & (K Pcs)
Table 115. Global Biosimilars/Follow-on-Biologics Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Biosimilars/Follow-on-Biologics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Biosimilars/Follow-on-Biologics Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilars/Follow-on-Biologics
Figure 2. Global Biosimilars/Follow-on-Biologics Market Share by Type in 2020 & 2027
Figure 3. Human Growth Hormone Product Picture
Figure 4. Erythropoietin Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Insulin Product Picture
Figure 7. Interferon Product Picture
Figure 8. Granulocyte-Colony Stimulating Factor Product Picture
Figure 9. Peptide Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biosimilars/Follow-on-Biologics Market Share by Application in 2020 & 2027
Figure 12. Blood Disorders
Figure 13. Oncology Diseases
Figure 14. Chronic and Autoimmune Diseases
Figure 15. Growth Hormone Deficiencies
Figure 16. Others
Figure 17. Global Biosimilars/Follow-on-Biologics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Biosimilars/Follow-on-Biologics Market Size 2016-2027 (US$ Million)
Figure 19. Global Biosimilars/Follow-on-Biologics Sales 2016-2027 (K Pcs)
Figure 20. Global Biosimilars/Follow-on-Biologics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 21. Biosimilars/Follow-on-Biologics Sales Share by Manufacturers in 2020
Figure 22. Global Biosimilars/Follow-on-Biologics Revenue Share by Manufacturers in 2020
Figure 23. The Global 5 and 10 Largest Biosimilars/Follow-on-Biologics Players: Market Share by Revenue in 2020
Figure 24. Biosimilars/Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 25. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region (2016-2021)
Figure 26. Global Biosimilars/Follow-on-Biologics Sales Market Share by Region in 2020
Figure 27. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region (2016-2021)
Figure 28. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Region in 2020
Figure 29. U.S. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Canada Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Germany Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. France Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. U.K. Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Italy Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Japan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. South Korea Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. India Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Australia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Taiwan Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Indonesia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Thailand Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Malaysia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Philippines Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Vietnam Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Mexico Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Brazil Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Argentina Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Turkey Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Saudi Arabia Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.A.E Biosimilars/Follow-on-Biologics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Sales Market Share of Biosimilars/Follow-on-Biologics by Type (2016-2021)
Figure 54. Sales Market Share of Biosimilars/Follow-on-Biologics by Application (2016-2021)
Figure 55. Sales Market Share of Biosimilars/Follow-on-Biologics by Application in 2020
Figure 56. Revenue Share of Biosimilars/Follow-on-Biologics by Application (2016-2021)
Figure 57. Revenue Share of Biosimilars/Follow-on-Biologics by Application in 2020
Figure 58. Manufacturing Cost Structure of Biosimilars/Follow-on-Biologics
Figure 59. Manufacturing Process Analysis of Biosimilars/Follow-on-Biologics
Figure 60. Biosimilars/Follow-on-Biologics Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed